ClinVar Miner

Submissions for variant NM_001844.5(COL2A1):c.3106C>T (p.Arg1036Ter)

dbSNP: rs748459670
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000479858 SCV000230653 pathogenic not provided 2015-09-29 criteria provided, single submitter clinical testing
GeneDx RCV000479858 SCV000568530 pathogenic not provided 2023-06-23 criteria provided, single submitter clinical testing Has been reported in multiple individuals with Stickler syndrome (Richards et al., 2006; Hoornaert et al., 2010; Richards et al., 2010; Savasta et al., 2015; Barat-Houari et al., 2016a; Kondo et al., 2016; Huang et al., 2020; Choi et al., 2021); Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25809783, 25525159, 16752401, 20179744, 23891399, 29453956, 26443184, 27408751, 29661559, 20513134, 34680973, 32756486)
Mendelics RCV000988819 SCV001138704 pathogenic Stickler syndrome type 1 2019-05-28 criteria provided, single submitter clinical testing
Invitae RCV000479858 SCV001581178 pathogenic not provided 2023-11-07 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg1036*) in the COL2A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL2A1 are known to be pathogenic (PMID: 20179744). This variant is present in population databases (rs748459670, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Stickler syndrome type 1 (PMID: 16752401, 25809783). ClinVar contains an entry for this variant (Variation ID: 197503). For these reasons, this variant has been classified as Pathogenic.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000479858 SCV004564461 pathogenic not provided 2023-02-27 criteria provided, single submitter clinical testing The COL2A1 c.3106C>T; p.Arg1036Ter variant (rs748459670) is reported in the literature in individuals with Stickler syndrome (Choi 2021, Richards 2006, Savasta 2015). This variant is also reported in ClinVar (Variation ID: 197503). It is only found on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Choi SI et al. Genetic Characteristics and Phenotype of Korean Patients with Stickler Syndrome: A Korean Multicenter Analysis Report No. 1. Genes (Basel). 2021 Oct 5;12(10):1578. PMID: 34680973. Richards AJ et al. High efficiency of mutation detection in type 1 stickler syndrome using a two-stage approach: vitreoretinal assessment coupled with exon sequencing for screening COL2A1. Hum Mutat. 2006 Jul;27(7):696-704. PMID: 16752401. Savasta S et al. Stickler syndrome associated with epilepsy: report of three cases. Eur J Pediatr. 2015 May;174(5):697-701. PMID: 25809783.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.